Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 15 de 15
Filter
Add more filters










Publication year range
1.
Arch Soc Esp Oftalmol (Engl Ed) ; 94(10): 514-517, 2019 Oct.
Article in English, Spanish | MEDLINE | ID: mdl-31171387

ABSTRACT

We report the case of a 68-year-old man with a left lower eyelid basal cell carcinoma with squamous differentiation. Resection was performed under frozen section technique and the defect (inner canthus, two thirds of the lower eyelid and 2.5cm of the cheek) reconstructed 2 days after surgery in a single surgical operation: posterior lamella with pericranial graft and anterior lamella with Mustarde flap. After one year of follow-up, the patient has an adequate appearance, good eyelid support and position, vascularized tissue like the native eyelid and no tumor recurrence.


Subject(s)
Blepharoplasty/methods , Carcinoma, Basal Cell/surgery , Eyelid Neoplasms/surgery , Periosteum/transplantation , Surgical Flaps , Aged , Humans , Male , Skull
2.
Arch. Soc. Esp. Oftalmol ; 93(12): 606-609, dic. 2018. ilus
Article in Spanish | IBECS | ID: ibc-175155

ABSTRACT

CASO CLÍNICO: Un varón de 70 años, procedente de Sicilia, acude con una masa palpebral bilateral con afectación tarsal conjuntival, que resultó ser un sarcoma de Kaposi al examen histológico. Se demostró afectación cutánea y pulmonar por el sarcoma de Kaposi. El paciente no tenía un diagnóstico previo de infección por el virus de la inmunodeficiencia humana. Este caso fue tratado con éxito tras 5 ciclos de quimioterapia con doxorrubicina liposomal, con resolución de las lesiones palpebrales, cutáneas y pulmonares. Conclusiones: La localización en el párpado es una posible manifestación inicial, aunque rara, del sarcoma de Kaposi en personas de edad avanzada negativos para el virus de la inmunodeficiencia humana. La doxorrubicina liposomal es un tratamiento seguro y efectivo


CASE REPORT: We report a case of 70-year-old male from Sicily, who presented with a bilateral eyelid mass involving the tarsal conjunctiva, found to be Kaposi's sarcoma on histologic examination. Cutaneous and pulmonary Kaposi's sarcoma involvement was documented. The patient had no prior diagnosis of human immunodeficiency virus infection. This case was managed successfully after the completion of five cycles of chemotherapy with liposomal doxorubicin, and his eyelid, skin and pulmonary lesions disappeared. CONCLUSIONS: Location in the eyelid is a possible, though rare, initial solitary manifestation of Kaposi's sarcoma in elderly HIV-negative patients. Liposomal doxorubicin is a safe and effective treatment


Subject(s)
Humans , Male , Aged , Sarcoma, Kaposi/complications , Eyelid Diseases/pathology , Doxorubicin/therapeutic use , Visual Acuity , Biopsy , HIV Seronegativity , Conjunctiva/pathology , Eyelids/pathology , Diagnosis, Differential , Immunohistochemistry , Enzyme-Linked Immunosorbent Assay , Blotting, Western , Sarcoma, Kaposi/diagnostic imaging , Sarcoma, Kaposi/therapy
4.
Arch Soc Esp Oftalmol (Engl Ed) ; 93(12): 606-609, 2018 Dec.
Article in English, Spanish | MEDLINE | ID: mdl-30055902

ABSTRACT

CASE REPORT: We report a case of 70-year-old male from Sicily, who presented with a bilateral eyelid mass involving the tarsal conjunctiva, found to be Kaposi's sarcoma on histologic examination. Cutaneous and pulmonary Kaposi's sarcoma involvement was documented. The patient had no prior diagnosis of human immunodeficiency virus infection. This case was managed successfully after the completion of five cycles of chemotherapy with liposomal doxorubicin, and his eyelid, skin and pulmonary lesions disappeared. CONCLUSIONS: Location in the eyelid is a possible, though rare, initial solitary manifestation of Kaposi's sarcoma in elderly HIV-negative patients. Liposomal doxorubicin is a safe and effective treatment.


Subject(s)
Antibiotics, Antineoplastic/therapeutic use , Doxorubicin/analogs & derivatives , Eyelid Neoplasms/drug therapy , Neoplasms, Multiple Primary/drug therapy , Sarcoma, Kaposi/drug therapy , Aged , Doxorubicin/therapeutic use , Eyelid Neoplasms/diagnostic imaging , HIV Seronegativity , Humans , Male , Neoplasms, Multiple Primary/diagnostic imaging , Polyethylene Glycols/therapeutic use , Remission Induction , Sarcoma, Kaposi/diagnostic imaging , Tomography, X-Ray Computed
7.
Arch. Soc. Esp. Oftalmol ; 90(12): 588-592, dic. 2015. ilus
Article in Spanish | IBECS | ID: ibc-145848

ABSTRACT

CASO CLÍNICO: Miope magna con cámara anterior estrecha que presentó cierre angular secundario a lorazepam. DISCUSIÓN: El cierre angular generalmente ocurre en pacientes predispuestos desencadenado por factores precipitantes. Muchos fármacos de uso rutinario en la práctica clínica podrían ejercer como factor responsable del cierre angular secundario


CASE REPORT: Myopic magna with narrow anterior chamber that presented with a secondary angle closure due to lorazepam. DISCUSSION: Angle closure usually occurs in predisposed patients and is triggered by precipitating factors. Many drugs routinely used in clinical practice could act as a factor responsible for the secondary angle closure


Subject(s)
Adult , Female , Humans , Myopia/chemically induced , Myopia/complications , Lorazepam/adverse effects , Lorazepam/therapeutic use , Secondary Effect , Vision, Ocular , Vision Disorders/chemically induced , Vision Disorders/complications , Tomography, Optical Coherence/methods , Intraocular Pressure , Acetazolamide/therapeutic use , Ophthalmic Solutions/therapeutic use , Fundus Oculi , Tomography, Optical Coherence/instrumentation , Tomography, Optical Coherence
13.
Arch Soc Esp Oftalmol ; 90(12): 588-92, 2015 Dec.
Article in English, Spanish | MEDLINE | ID: mdl-25817467

ABSTRACT

CASE REPORT: Myopic magna with narrow anterior chamber that presented with a secondary angle closure due to lorazepam. DISCUSSION: Angle closure usually occurs in predisposed patients and is triggered by precipitating factors. Many drugs routinely used in clinical practice could act as a factor responsible for the secondary angle closure.


Subject(s)
Cholinergic Antagonists/adverse effects , Glaucoma, Angle-Closure/chemically induced , Lorazepam/adverse effects , Mydriatics/adverse effects , Myopia/complications , Acetazolamide/therapeutic use , Cholinergic Antagonists/pharmacology , Cholinergic Antagonists/therapeutic use , Combined Modality Therapy , Depression/drug therapy , Dexamethasone/therapeutic use , Disease Susceptibility , Female , Humans , Intraocular Pressure/drug effects , Iris/surgery , Lorazepam/pharmacology , Lorazepam/therapeutic use , Mydriatics/therapeutic use , Timolol/therapeutic use , Tomography, Optical Coherence , Visual Field Tests , Young Adult
14.
SELECTION OF CITATIONS
SEARCH DETAIL
...